Making Over Your Portfolio? Avoid These Lemons
These sour investment laggards may be worth tossing from your portfolio.
No matter where we are in the economic cycle, investors can still help their own portfolios. That's the spirit behind Morningstar's Portfolio Makeover Week, which features before and after portfolios of real-life investors as well as plenty of how-tos for improving your own portfolio.
Because building a successful portfolio is as much about avoiding investment duds as it is about identifying winning holdings, we turned to the Premium Fund and Stock Screener to filter for some investment disappointments that don't make the cut in any market.
To home in on lemon funds, we leveraged the work of our in-house fund analyst staff by screening for Analyst Pans--funds that they have deemed unsuitable investment options. Of those, we sought out distinct portfolios of funds that hold at least $250 million in assets. The screener yielded a total of 13 funds, two of which we highlight below. You can replicate this screen by clicking here.
Esther Pak does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.